key: cord-0786970-qm44flh4 authors: Klaassen, Kristel; Stankovic, Biljana; Zukic, Branka; Kotur, Nikola; Gasic, Vladimir; Pavlovic, Sonja; Stojiljkovic, Maja title: Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection date: 2020-05-13 journal: bioRxiv DOI: 10.1101/2020.05.13.093690 sha: 2bd6bdfae9757ae1e18cceefc4be91b8eed0eef6 doc_id: 786970 cord_uid: qm44flh4 New coronavirus SARS-CoV-2 is capable to infect humans and cause a novel disease COVID-19. Aiming to understand a host genetic component of COVID-19, we focused on variants in genes encoding proteases and genes involved in innate immunity that could be important for susceptibility and resistance to SARS-CoV-2 infection. Analysis of sequence data of coding regions of FURIN, PLG, PRSS1, TMPRSS11a, MBL2 and OAS1 genes in 143 unrelated individuals from Serbian population identified 22 variants with potential functional effect. In silico analyses (PolyPhen-2, SIFT, MutPred2 and Swiss-Pdb Viewer) predicted that 10 variants could impact the structure and/or function of proteins. These protein-altering variants (p.Gly146Ser in FURIN; p.Arg261His and p.Ala494Val in PLG; p.Asn54Lys in PRSS1; p.Arg52Cys, p.Gly54Asp and p.Gly57Glu in MBL2; p.Arg47Gln, p.Ile99Val and p.Arg130His in OAS1) may have predictive value for inter-individual differences in the response to the SARS-CoV-2 infection. Next, we performed comparative population analysis for the same variants using extracted data from the 1000 genomes project. Population genetic variability was assessed using delta MAF and Fst statistics. Our study pointed to 7 variants in PLG, TMPRSS11a, MBL2 and OAS1 genes with noticeable divergence in allelic frequencies between populations worldwide. Three of them, all in MBL2 gene, were predicted to be damaging, making them the most promising population-specific markers related to SARS-CoV-2 infection. Comparing allelic frequencies between Serbian and other populations, we found that the highest level of genetic divergence related to selected loci was observed with African, followed by East Asian, Central and South American and South Asian populations. When compared with European populations, the highest divergence was observed with Italian population. In conclusion, we identified 4 variants in genes encoding proteases (FURIN, PLG and PRSS1) and 6 in genes involved in the innate immunity (MBL2 and OAS1) that might be relevant for the host response to SARS-CoV-2 infection. We postulate that the variants in genes encoding proteases could be advantageous, while variants in genes encoding proteins involved in the innate immunity add some disadvantage to individuals in combating COVID-19. We also performed comparative genetic analysis in different populations in order to assess the divergence between populations for those variants. In this study, we analyzed the genomic sequence data of unrelated individuals from Serbian population, extracted from the in-house database of Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade. Written informed consent was obtained from all participants. The study was conducted in accordance with the Helsinki Declaration and approved by the Ethic Committee of Institute of Molecular Genetics and Genetic Engineering, University of Belgrade. Total of 143 unrelated Serbian individuals (84 males and 59 females) were previously analyzed by NGS approach using the Illumina Clinical Exome Sequencing TruSight One Gene Panel (Illumina, San Diego, CA, USA), as previously described [23] . VCF files were further annotated and examined using the Illumina VariantStudio 3.0 Data Analysis Software (Illumina, San Diego, CA, USA). Variants that did not pass variant call quality filters (those with quality score 8) in more than 10% of samples were excluded. Variants that were considered for further analysis were either missense, start loss, stop gain, splice region variants and frameshift, while synonymous variants were omitted. For all selected variants, Hardy-Weinberg equilibrium was tested, using the chi square goodness of fit test. Next, we compared genotype data from Serbian population with European (Italy, Spain, Finland, Great Britain and USA with European ancestry), as well as other 4 super-populations, Eastern Asians, South Asians, African and Ad Mixed American -Central and South American populations (total of 2504 subjects). Genotype data were extracted from the VCF files of Phase 3 variant calls of the 1000 Genomes Project (1kGP) sample collection (https://www.internationalgenome.org/) via Ensembl Data Slicer Tool. Populations and details regarding the 1kGP data were described previously [24] . Fisher exact test was used to measure significant differences in genotypes distributions between Serbian and 1kGP populations, applying Bonferoni correction for multiple testing. We examined the level of population genetic variability at each selected loci using: (1) the maximal global differences in minor allele frequencies (delta MAF) calculated by subtracting the maximum and the minimum MAF across analyzed population groups, (2) using Fst statistics [25] , which is widely used in population genetics [26] . R software was utilized for genotype data manipulation, statistical calculations as well as graphical presentations. For estimating Fst statistics, R packages adegenet and hierfstat were used. Next, we performed in silico prediction analysis of the identified variants' effect, using PolyPhen-2, SIFT and MutPred2 algorithms (Table 1) . Nine missense variants were predicted to Other 2 variants with potentially damaging effect, p.Arg52Cys and p.Gly54Glu in MBL2 gene, having allelic frequency of 8% and 14%, respectively, are the most promising population-specific markers to be considered for association study in COVID-19 patients in Serbia. In total, 4 variants in genes encoding proteases (FURIN, PLG and PRSS1) and 6 in genes involved in the innate immunity (MBL2 and OAS1) might be interesting for further studies in relation to the response to SARS-CoV-2 infection. Our next goal was to investigate the allele frequency in populations worldwide for the same receptor which contribute to susceptibility to some strains of HIV infection, while variants in CCR5 gene provide resistance to its carriers [27, 28] . Recent studies addressed rare variants in ACE2 gene which could directly influence the binding to S protein of the SARS-CoV-2 and the population-specific differences of more frequent ACE2 gene variants [21, 22] . However, having in mind complexity of the interaction between the virus and the host, which besides the S protein -ACE2 receptor interaction, includes the role of different host proteases and at least some elements of innate immunity with antiviral activity, in this study we selected additional genes that could be important for the susceptibility or resistance to the SARS-CoV-2 viral infection. We focused on genetic variants in genes FURIN, PLG, PRSS1, TMPRSS11a, that encode proteases, as well as variants in genes MBL2 and OAS1, that encode proteins involved in innate immunity, attempting to find promising candidate alleles that might be included in the future genetic test related to new waives of the SARS-CoV-2 pandemics. To systematically examine the coding variants in selected genes and differences in the allele frequency between populations, we performed comparative analysis of 22 variants found in FURIN, PLG, PRSS1, TMPRSS11a, MBL2 and OAS1 genes from Serbian population database with different European populations and super-populations extracted from 1kGP database [24] . Also, we used bioinformatic tools to predict the effect of these genetic variants on the structure and/or function of proteins encoded by FURIN, PLG, PRSS1, TMPRSS11a, MBL2 and OAS1 genes. It could be possible that the existence of variants in genes encoding proteases provide advantage while variants in genes for proteins involved in the innate immunity add some disadvantage to individuals in combating COVID-19. individuals with elevated plasmin had greater susceptibility to COVID-19 and more severe clinical manifestations [20] , rare variants in PLG, such as p.Arg261His and p.Ala494Val may be recognized as potential markers of inter-individual differences in susceptibility to coronavirus. Trypsin-1 is encoded by the PRSS1 gene which is a member of the trypsin-1 family of serine proteases. It is active on peptide linkages involving the carboxyl group of lysine or arginine. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is also present in airway and alveolar type I and II epithelial cells [20] . Two rare variants in the PRSS1 gene, c.592-8C>T and p.Asn54Lys, were detected. Variant c.592-8C>T was previously detected in patients with cystic fibrosis presenting with chronic pancreatitis [33] . Given that this is a splice region variant, it may affect splicing and therefore the level of trypsin-1 protein. Trypsin-1 variant p.Asn54Lys leads to the substitution of polar asparagine residue to a positively charged lysine. This variant is predicted to be possibly damaging/deleterious by PolyPhen-2 and SIFT algorithms, while MutPred2 software suggested that this change may alter the catalytic site. Given that the catalytic triad of trypsin-1 enzyme is consisted of His57, Asn102 and Ser195 [34] , the proximity of Asn54 to His57 might modify the enzymatic activity. The same codon is affected by an alternative variant, p.Asn54Ser, which was classified pathogenic by UniProt, and associated with chronic pancreatitis [35, 36] . Nevertheless, having in mind that the variant p.Asn54Lys was observed in healthy adults, this variant is not regarded as a disease causing in the context of Mendelian diseases. Its mechanism might be through the fine modification of trypsin-1 enzymatic activity, which could contribute to the resistance of some individuals to SARS-CoV-2 infection. Transmembrane serine protease 11A, encoded by the TMPRSS11a gene is one of the members of type II transmembrane serine proteases and it is present in upper respiratory tract (pharynx and trachea) and digestive tract [30] . Two rare variants were detected in the TMPRSS11A gene: p.Lys48Arg and p.Arg328Gln. For both of these variants, PolyPhen-2, SIFT and MutPred2 algorithms predict benign/tolerated effect. Given the scarce data on the protein structure of TMPRSS11A, the effect of this variants is yet to be ascertained. Innate immunity is important in defending organism from viral infections. After SARS-CoV outbreak it was found that type I interferons could inhibit the replication of this virus and that these interferons further induce different proteins with antiviral activity [37] . One of such proteins is encoded by the OAS1 gene. OAS1 synthesizes 2',5'-oligoadenylates, and as a consequence activates latent RNase L which cuts single-stranded RNAs thus leading to the viral RNA degradation and inhibition of viral replication [38] . Three rare variants were detected in the OAS1 gene: p.Arg47Gln, p.Ile99Val and p.Arg130His. Interestingly, human OAS1 protein recognizes two adjacent minor grooves of dsRNA with C-terminal lobe and N-terminal lobe, where the Arg47 residue is one of the residues involved in the recognition [39] . When analyzed in Swiss-Pdb Viewer, the side chain of Arg47 residue was predicted to form hydrogen bond with dsRNA, while a change to glutamine at this position was predicted to abolish this hydrogen bond. Furthermore, Gln at this position is predicted to form hydrogen bonds with Cys45 and Phe46, and also to cause steric clashes with Glu43 and Arg44. Nevertheless, variant p.Arg47Gln is predicted to be benign/tolerated by PolyPhen-2, SIFT and MutPred2 algorithms, so its effect on the OAS1 protein seems not to affect the structure itself, but it may be apparent upon the binding of the dsRNA. Variant p.Ile99Val is predicted to be possibly damaging/deleterious by prediction algorithms, but the analysis in Swiss-Pdb Viewer revealed that the backbone of the Ile99 residue is predicted to form hydrogen bonds with Arg95, Gly96 and Arg103, so the change to Val at this position did not change the existing bonds, nor did it form novel ones. Variant p.Arg130His is predicted to be probably damaging/deleterious by prediction algorithms, and the analysis in Swiss-Pdb Viewer showed that in case of Arg130, a change to His at this position was predicted to result in the formation of novel hydrogen bonds with Thr188 and also a steric clash with Glu185. These rare variants may have an effect on the OAS1 structure and/or function through the formation of novel hydrogen bonds and steric clashes, leading to a less stable protein. In case of variants located at the protein/RNA interface formed upon the binding, its effects reflect on the formation of (to some extent) weaker bond with the RNA thus lowering its 2'-5'-oligoadenylate synthetase activity, as it was shown that variants at the protein/RNA interface impair OAS1 activity by 60-to 2,500-fold [39] . Furthermore, having in mind that the active form of human OAS1 is tetrameric, any variant potentially impairing the oligomerization process would also have an effect on the activity of the enzyme, the synthesis of 2',5'-oligoadenylates, and consequently the activation of the latent RNase and the degradation of viral RNA of SARS-CoV-2. Knowing that variants in OAS1, such as p.Gly397Arg were previously associated with susceptibility to SARS-CoV infection in some populations [5] , the effects of p.Arg47Gln, p.Ile99Val and p.Arg130His might be interesting for further investigation. The comparative population analysis pointed to the 7 coding variants in PLG, TMPRSS11a, MBL2 and OAS1 with noticeable divergence in allelic frequencies between analyzed populations. [42] and multiple sclerosis [43] , but a more recent study showed that this variant was found not to interfere with OAS1 enzyme activity [44] . Another important element of the innate immune system is mannose-binding protein (soluble mannose-binding lectin) which is encoded by the MBL2 gene. The protein recognizes mannose and N-acetylglucosamine expressed on the surface of many microorganisms, and is capable of activating the classical complement pathway. Deficiencies of this gene have been associated with increased susceptibility to SARS-CoV and other autoimmune and infectious diseases [6] . Interestingly, out of 7 genetic variants that demonstrated delta MAF>0.1 in our study, only p.Arg52Cys, p.Gly54Asp and p.Gly57Glu in MBL2 were predicted to be probably damaging/deleterious by prediction algorithms. Moreover, these three variants were already extensively studied and functionally characterized -they showed compromised oligomerization and thus the activity of the final protein [45] . In addition to promoter variants, these coding variants have been shown to influence the stability and serum concentration of the protein, where, consequently, low levels of MBL2 have been associated with increased susceptibility to infections [46] . Therefore, the influence of these three variants was studied in various immunological sceneries, from autoimmune to infections, including SARS-CoV [6, 47] . Nevertheless, all three Taken altogether, comparing Serbian to other populations, it was found that the highest level of genetic differentiation related to selected loci was observed with African, followed by East Asian and South Asian populations. When compared with European populations, the highest divergence was observed with Italian population. In conclusion, results of our analysis showed that variants predicted to have altering effect to the proteins are very rare in each of the selected European populations as well as super-populations. Thus, although it is not likely to perform massive genetic testing aiming to detect these variants in order to predict prognosis to COVID-19, they may provide answers for the inter-individual differences in the clinical course of disease among patients of the same age and the same genetic background which received identical medical treatment. On the other hand, variants which have divergent allele frequencies between populations were mostly predicted to lack effect on the structure and/or the function of the proteins. However, few variants, such as those in MBL2 gene were predicted to have some functional effect and their contribution to population differences regarding COVID-19 should be further evaluated. In general, findings of this study may lead us to conclude that 4 coding variants in genes encoding proteases (FURIN, PLG and PRSS1) and 6 in genes involved in the innate immunity (MBL2 and OAS1) could be considered as candidates in forthcoming studies aiming to explain differences in clinical manifestations, recovery rate and mortality rate of COVID-19 which vary between different populations [48] . Further genetic analysis of variants in the non-coding regions (contributing to the fine tuning of the gene expression) of these genes, as well as variants in other genes, are needed to complement our study and give the complete insight about inter-individual and population-specific genetic susceptibility and resistance to the SARS-CoV-2 infection. A global genetic initiative [49] holds promise that the full spectrum of human genetic factors determining susceptibility, severity and outcomes of COVID-19 will be determined in future. A new coronavirus associated with human respiratory disease in China PubMed Central PMCID: PMC7094943. 2. WHO. Available from Human Genetic Determinants of Viral Diseases. Annual review of genetics Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study Functional polymorphisms of the CCL2 MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection AHSG) gene associated with the risk of SARS-CoV infection The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome genotype in patients infected with severe acute respiratory syndrome-associated coronavirus. Clinical and vaccine immunology : CVI Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severity. Hong Kong medical journal = Xianggang yi xue za zhi Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation Plasmin improves oedematous blood-gas barrier by cleaving epithelial sodium channels. British journal of pharmacology Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. Journal of medical virology Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants A global reference for human genetic variation Molecular Evolutionary Genetics: Columbia University Press Genetics in geographically structured populations: defining, estimating and interpreting F(ST) Resistance to HIV infection A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers. The Journal of infectious diseases Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism The X-ray crystal structure of full-length human plasminogen Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis The catalytic triad of serine peptidases. Cellular and molecular life sciences : CMLS Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Treatment of SARS with human interferons Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1 PubMed Central PMCID: PMC2423485 is a consultant for the Robert Michael Educational Institute. Guochun Liao, Jonathan Usuka and Gary Peltz are employees of Roche Biosciences Differential Cumulative Risk of Genetic Polymorphisms in Familial and Nonfamilial Esophageal Squamous Cell Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research Reassessment of the type I diabetes association of the OAS1 OAS1 gene haplotype confers susceptibility to multiple sclerosis Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism Disease-associated mutations in human mannosebinding lectin compromise oligomerization and activity of the final protein Mannose-binding lectin and its genetic variants Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. The Journal of infectious diseases